No abstract available
Keywords:
CD127+ ILCs; acute myeloid leukemia; dysregulated; innate lymphoid cells; treatment naive.
Publication types
-
Letter
-
Research Support, Non-U.S. Gov't
MeSH terms
-
Adult
-
Aged
-
Antineoplastic Agents / therapeutic use
-
Case-Control Studies
-
Cell Lineage / drug effects
-
Cell Lineage / immunology*
-
Cytarabine / therapeutic use
-
Daunorubicin / therapeutic use
-
Female
-
Gene Expression
-
Humans
-
Immunity, Innate
-
Immunophenotyping
-
Interferon-gamma / biosynthesis
-
Interferon-gamma / immunology
-
Interleukin-7 Receptor alpha Subunit / genetics
-
Interleukin-7 Receptor alpha Subunit / immunology*
-
Interleukins / biosynthesis
-
Interleukins / immunology
-
Leukemia, Myeloid, Acute / diagnosis
-
Leukemia, Myeloid, Acute / immunology
-
Leukemia, Myeloid, Acute / pathology*
-
Leukemia, Myeloid, Acute / therapy
-
Lymphocytes / classification
-
Lymphocytes / drug effects
-
Lymphocytes / immunology
-
Lymphocytes / pathology*
-
Male
-
Middle Aged
-
Treatment Outcome
-
Tumor Necrosis Factor-alpha / biosynthesis
-
Tumor Necrosis Factor-alpha / immunology
Substances
-
Antineoplastic Agents
-
Interleukin-7 Receptor alpha Subunit
-
Interleukins
-
Tumor Necrosis Factor-alpha
-
Cytarabine
-
Interferon-gamma
-
Daunorubicin